SCHEMBL6784847

SCHEMBL6784847

Cn1ncc2[nH]c3cccc(-c4cccc(O)c4)c3c(=O)c21

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK4 P11802 1/20 0.39
CCND1 P24385 1/20 0.39
CHEK1 O14757 2/20 0.38
WEE1 P30291 2/20 0.38
RET P07949 2/20 0.36
MGAM O43451 1/20 0.36
GAA P10253 1/20 0.36
SI P14410 1/20 0.36
MGAM2 Q2M2H8 1/20 0.36
PLK4 O00444 1/20 0.36
ROCK2 O75116 1/20 0.36
RPS6KA5 O75582 1/20 0.36
MAP4K4 O95819 1/20 0.36
PDGFRB P09619 1/20 0.36
PIM1 P11309 1/20 0.36
FGFR1 P11362 1/20 0.36
SRC P12931 1/20 0.36
PDGFRA P16234 1/20 0.36
PRKACA P17612 1/20 0.36
RPS6KB1 P23443 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6782186 0.88 CDK4 (0.38) CDK4CCND1CHEK1WEE1RET
SCHEMBL6784780 0.84 PRMT5 (0.44) CHEK1WEE1GAAMAP4K4PIM1
SCHEMBL6784727 0.81 KDR (0.43) CHEK1RETPLK4MAP4K4PDGFRB
SCHEMBL6782703 0.80 KIF11 (0.43) CDK4CCND1CHEK1WEE1GAA
Hydrochloric Acid SCHEMBL6785628 0.80 KDR (0.42) CHEK1RETPLK4MAP4K4PDGFRB
SCHEMBL6788209 0.79 PARP1 (0.42) GAAMAP2K1PARP1
SCHEMBL6788043 0.75 FEN1 (0.42) CDK4CCND1CHEK1WEE1RET
SCHEMBL6785738 0.74 POLB (0.39) GAACDK2
SCHEMBL6781822 0.73 DAO (0.34) GAACDK2PARP1
SCHEMBL6787796 0.70 KIF11 (0.39) GAAKIF11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6686373-B2 ANALGESICS; ANTIINFLAMMATORY AGENT WARNER-LAMBERT COMPANY LLC 2004-02-03 US disclosed
US-20030130277-A1 Pyrazoloquinolinone derivatives as protein kinase C inhibitors KAWAMURA KIYOSHI (JP) 2003-07-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030130277-A1 Pyrazoloquinolinone derivatives as protein kinase C inhibitors PRKCB, PRKCA, PRKCG CDK4 1267/4885CCND1 1653/4885CHEK1 339/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.